Literature DB >> 23110865

Standardization of analysis sets for reporting results from ADNI MRI data.

Bradley T Wyman1, Danielle J Harvey, Karen Crawford, Matt A Bernstein, Owen Carmichael, Patricia E Cole, Paul K Crane, Charles DeCarli, Nick C Fox, Jeffrey L Gunter, Derek Hill, Ronald J Killiany, Chahin Pachai, Adam J Schwarz, Norbert Schuff, Matthew L Senjem, Joyce Suhy, Paul M Thompson, Michael Weiner, Clifford R Jack.   

Abstract

The Alzheimer's Disease Neuroimaging Initiative (ADNI) three-dimensional T1-weighted magnetic resonance imaging (MRI) acquisitions provide a rich data set for developing and testing analysis techniques for extracting structural endpoints. To promote greater rigor in analysis and meaningful comparison of different algorithms, the ADNI MRI Core has created standardized analysis sets of data comprising scans that met minimum quality control requirements. We encourage researchers to test and report their techniques against these data. Standard analysis sets of volumetric scans from ADNI-1 have been created, comprising screening visits, 1-year completers (subjects who all have screening, 6- and 12-month scans), 2-year annual completers (screening, 1-year and 2-year scans), 2-year completers (screening, 6-months, 1-year, 18-months [mild cognitive impaired (MCI) only], and 2-year scans), and complete visits (screening, 6-month, 1-year, 18-month [MCI only], 2-year, and 3-year [normal and MCI only] scans). As the ADNI-GO/ADNI-2 data become available, updated standard analysis sets will be posted regularly.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23110865      PMCID: PMC3891834          DOI: 10.1016/j.jalz.2012.06.004

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  8 in total

1.  The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes.

Authors:  Laurel A Beckett; Danielle J Harvey; Anthony Gamst; Michael Donohue; John Kornak; Hao Zhang; Julie H Kuo
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 2.  Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.

Authors:  Clifford R Jack; Matt A Bernstein; Bret J Borowski; Jeffrey L Gunter; Nick C Fox; Paul M Thompson; Norbert Schuff; Gunnar Krueger; Ronald J Killiany; Charles S Decarli; Anders M Dale; Owen W Carmichael; Duygu Tosun; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 3.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 4.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

5.  Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils.

Authors:  Richard G Boyes; Jeff L Gunter; Chris Frost; Andrew L Janke; Thomas Yeatman; Derek L G Hill; Matt A Bernstein; Paul M Thompson; Michael W Weiner; Norbert Schuff; Gene E Alexander; Ronald J Killiany; Charles DeCarli; Clifford R Jack; Nick C Fox
Journal:  Neuroimage       Date:  2007-10-30       Impact factor: 6.556

6.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

7.  Comparison of phantom and registration scaling corrections using the ADNI cohort.

Authors:  Matthew J Clarkson; Sébastien Ourselin; Casper Nielsen; Kelvin K Leung; Josephine Barnes; Jennifer L Whitwell; Jeffrey L Gunter; Derek L G Hill; Michael W Weiner; Clifford R Jack; Nick C Fox
Journal:  Neuroimage       Date:  2009-05-27       Impact factor: 6.556

8.  The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Authors:  Clifford R Jack; Matt A Bernstein; Nick C Fox; Paul Thompson; Gene Alexander; Danielle Harvey; Bret Borowski; Paula J Britson; Jennifer L Whitwell; Chadwick Ward; Anders M Dale; Joel P Felmlee; Jeffrey L Gunter; Derek L G Hill; Ron Killiany; Norbert Schuff; Sabrina Fox-Bosetti; Chen Lin; Colin Studholme; Charles S DeCarli; Gunnar Krueger; Heidi A Ward; Gregory J Metzger; Katherine T Scott; Richard Mallozzi; Daniel Blezek; Joshua Levy; Josef P Debbins; Adam S Fleisher; Marilyn Albert; Robert Green; George Bartzokis; Gary Glover; John Mugler; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2008-04       Impact factor: 4.813

  8 in total
  73 in total

1.  Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.

Authors:  Miguel Ángel Araque Caballero; Matthias Brendel; Andreas Delker; Jinyi Ren; Axel Rominger; Peter Bartenstein; Martin Dichgans; Michael W Weiner; Michael Ewers
Journal:  Neurobiol Aging       Date:  2015-08-18       Impact factor: 4.673

2.  Early detection of Alzheimer's disease using MRI hippocampal texture.

Authors:  Lauge Sørensen; Christian Igel; Naja Liv Hansen; Merete Osler; Martin Lauritzen; Egill Rostrup; Mads Nielsen
Journal:  Hum Brain Mapp       Date:  2015-12-21       Impact factor: 5.038

3.  Insulin-like growth factor binding protein-2 interactions with Alzheimer's disease biomarkers.

Authors:  Elizabeth M Lane; Timothy J Hohman; Angela L Jefferson
Journal:  Brain Imaging Behav       Date:  2017-12       Impact factor: 3.978

4.  Quantitative assessment of field strength, total intracranial volume, sex, and age effects on the goodness of harmonization for volumetric analysis on the ADNI database.

Authors:  Da Ma; Karteek Popuri; Mahadev Bhalla; Oshin Sangha; Donghuan Lu; Jiguo Cao; Claudia Jacova; Lei Wang; Mirza Faisal Beg
Journal:  Hum Brain Mapp       Date:  2018-11-15       Impact factor: 5.038

5.  Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease.

Authors:  Sahar Elahi; Alvin H Bachman; Sang Han Lee; John J Sidtis; Babak A Ardekani
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  Perivascular space fluid contributes to diffusion tensor imaging changes in white matter.

Authors:  Farshid Sepehrband; Ryan P Cabeen; Jeiran Choupan; Giuseppe Barisano; Meng Law; Arthur W Toga
Journal:  Neuroimage       Date:  2019-04-30       Impact factor: 6.556

7.  Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.

Authors:  Peng Yu; Jia Sun; Robin Wolz; Diane Stephenson; James Brewer; Nick C Fox; Patricia E Cole; Clifford R Jack; Derek L G Hill; Adam J Schwarz
Journal:  Neurobiol Aging       Date:  2013-10-03       Impact factor: 4.673

8.  Structural covariance of the default network in healthy and pathological aging.

Authors:  R Nathan Spreng; Gary R Turner
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

9.  Virtual Connectomic Datasets in Alzheimer's Disease and Aging Using Whole-Brain Network Dynamics Modelling.

Authors:  Lucas Arbabyazd; Kelly Shen; Zheng Wang; Martin Hofmann-Apitius; Petra Ritter; Anthony R McIntosh; Demian Battaglia; Viktor Jirsa
Journal:  eNeuro       Date:  2021-07-06

10.  Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.

Authors:  Xue Hua; Derrek P Hibar; Christopher R K Ching; Christina P Boyle; Priya Rajagopalan; Boris A Gutman; Alex D Leow; Arthur W Toga; Clifford R Jack; Danielle Harvey; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2012-11-12       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.